The reception by Geneva University Hospital of a batch of experimental rVSV Ebola vaccine developed at the National Microbiology Laboratory in Winnipeg, Canada October 22, 2014. (AFP/WHO/MATHILDE MISSIONEIRO)
Your feedback is important to us!
We invite all our readers to share with us their views and comments about this article.
Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.
Alert: If you are facing problems with posting comments, please note that you must verify your email with Disqus prior to posting a comment. follow this link to make sure your account meets the requirements. (http://bit.ly/vDisqus)
Tensions surrounding the Ebola epidemic raging in West Africa sparked a deadly riot in Sierra Leone as the World Health Organization prepared Wednesday to coordinate clinical trials of an experimental vaccine against the killer virus. Geneva saw the arrival of some 1,600 doses of the vaccine, which the WHO, under fire for what has been seen as a lethargic response to the outbreak, hopes can be fast-tracked into "real-world use". Meanwhile doctors said Wednesday two people died in a riot in eastern Sierra Leone the day before which erupted when health workers tried to take a blood sample from a 90-year-old woman suspected of having Ebola.
FOLLOW THIS ARTICLE